ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc. |
| [11-March-2025] |
NEW YORK, March 11, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by 2seventy bio, Inc. (NASDAQ: TSVT) and its board of directors concerning the proposed acquisition of the company by Bristol Myers Squibb (NYSE: BMY). Stockholders will receive $5.00 for each share of 2seventy bio stock that they hold. The transaction is valued at approximately $286 million and is expected to close in the second quarter of 2025. If you are a stockholder of 2seventy bio, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/tsvt/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free). Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC | ||
Company Codes: NASDAQ-NMS:TSVT, NYSE:BMY |
View original content:
